Semaglutide for women with PCOS and obesity
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests if a weekly injection called semaglutide can help women with PCOS and obesity lose weight and improve their health. It is for women who do not have other serious medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman of childbearing age (still having periods or able to get pregnant).
- You have been diagnosed with polycystic ovary syndrome (PCOS) by a doctor using the latest guidelines.
- You have obesity (your doctor has told you that you are obese).
- You do not have diabetes, serious kidney, liver, or heart disease.
- You have not used other weight loss pills or had weight loss surgery in the last 3 months.
- You are not pregnant, breastfeeding, or planning to get pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the medication semaglutide helps adults with overweight or obesity lose weight safely. It includes people with or without type 2 diabetes, and aims to see how well the drug works in a Bangladeshi population.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This trial tests whether semaglutide, a medication used for weight management, can improve the quality of embryos in women who are overweight or have obesity and are doing IVF. It aims to see if taking semaglutide before the IVF process helps make healthier embryos that can be frozen for later use.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This trial tests if semaglutide (a weekly injection) helps people who lost less weight than expected after gastric bypass or sleeve surgery. It's for patients who had a high BMI before surgery and are in a special support program.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.